Stryker is trading 6.21% down at $291.87 after its October 29 earnings report and lowered full-year outlook. - Adjusted earnings per share were $3.52, below estimates; management said quarterly performance fell short of expectations. - Stryker lowered its 2026 organic sales growth outlook to 6.5%–7.0% and adjusted earnings guidance to $14.80–$14.90 per share. Slower-than-planned growth and supply constraints added operational headwinds. - Broader healthcare strength was contrary context; no trading-volume figure was provided.